Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Endophilin B1 Inhibitors

Endophilin B1 inhibitors belong to a specialized class of chemical compounds designed to modulate the activity of the protein known as endophilin B1. Endophilins are a family of proteins involved in various cellular processes, particularly those related to membrane dynamics. Endophilin B1, a member of this family, plays a crucial role in mediating membrane curvature and facilitating vesicle formation, processes vital for cellular functions such as endocytosis and synaptic vesicle recycling. The inhibitors targeting endophilin B1 are meticulously crafted molecules designed to interfere with its normal functioning, ultimately influencing the intricate processes of membrane remodeling and vesicle trafficking within cells. The chemical structures of endophilin B1 inhibitors are diverse, reflecting the multifaceted nature of the interactions between these inhibitors and the target protein. These compounds typically feature specific functional groups and structural motifs that enable them to bind selectively to endophilin B1, disrupting its interactions with other cellular components. The mechanism of action involves the modulation of endophilin B1's ability to promote membrane curvature, thereby influencing vesicle formation and intracellular transport. Understanding the structure-activity relationships of endophilin B1 inhibitors is critical for designing potent compounds that can precisely target the protein without causing off-target effects. Researchers in the field aim to unravel the nuances of these inhibitors' interactions with endophilin B1, shedding light on the intricacies of cellular membrane dynamics and providing potential avenues for the development of novel tools for basic research.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$28.00
$53.00
37
(1)

Interferes with calcium signaling, which may affect SH3GLB1-involved autophagic processes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A known PI3K inhibitor, alters autophagy pathways in which SH3GLB1 participates.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

Inhibits class III PI3Ks, impacting the initial stages of autophagy involving SH3GLB1.

Saracatinib

379231-04-6sc-364607
sc-364607A
10 mg
200 mg
$115.00
$1056.00
7
(1)

Src kinase inhibitor that may disrupt downstream signaling affecting SH3GLB1's role in endocytosis.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor that could alter ERK pathway signaling, potentially influencing SH3GLB1 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor that might modulate pathways related to SH3GLB1's function in apoptosis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Another PI3K inhibitor that might affect SH3GLB1-related autophagy processes.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

p38 MAPK inhibitor which may indirectly influence SH3GLB1's role in stress response.

Necrostatin-1

4311-88-0sc-200142
sc-200142A
20 mg
100 mg
$94.00
$343.00
97
(3)

Inhibits RIP1 kinase, potentially affecting necroptotic pathways involving SH3GLB1.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

Inhibits calcineurin, thereby potentially influencing pathways that regulate SH3GLB1.